Sofia Lysenko’s parents moved to the United States from the Ukraine when she was 3 years old. Today, at 17, some of the biggest American pharmaceutical companies want to team up with this teenage science prodigy because she has created an artificial macromolecule robot that can deliver drugs directly to the brain cells of patients with Alzheimer’s and Parkinson’s. Iryna Matviichuk met with Sofia to learn more. Anna Rice narrates her report.
Joolam skype chat
news
- FDA proposes new testing rules to ensure cosmetics are asbestos-free 12/27/2024
- Bird flu virus shows mutations in first severe human case in US, agency says 12/27/2024
- US Congress fails to extend North Korean Human Rights Act 12/27/2024
- VOA Spanish: Key figures tapped for Trump’s presidency include critics of Venezuelan president 12/27/2024
- Taiwan seeks clarity on Trump team policy amid Chinese pressure 12/26/2024
subscribe via email
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
To find out more, including how to control cookies, see here: Cookie Policy